Robert Michael to succeed Gonzalez as Abbvie’s chair
Plus: Olazábal leaving Ysios and updates from Augustine and Prolific
Abbvie Inc. (NYSE:ABBV) CEO Robert Michael will succeed Richard Gonzalez as chairman on July 1. Gonzalez, who is retiring, became Abbvie’s chairman and CEO in 2013, handing off the CEO role to Michael last year.
Paula Olazábal is leaving Ysios Capital. Olazábal joined the European VC as an investment manager in 2008 and became partner in 2019. She’s yet to disclose her next adventure...